The stock price of China Pharma Holdings Inc. (AMEX: CPHI) has jumped by 6.67 compared to previous close of 0.19. Despite this, the company has seen a gain of 2.62% in its stock price over the last five trading days. prnewswire.com reported 2024-08-19 that HAIKOU, China , Aug. 19, 2024 /PRNewswire/ — China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma”, or the “Company”), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that through Hainan Helpson Medical and Biotechnology Co., Ltd. (“Helpson”), our wholly owned subsidiary, it expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 in China.
Is It Worth Investing in China Pharma Holdings Inc. (AMEX: CPHI) Right Now?
Moreover, the 36-month beta value for CPHI is 0.73. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CPHI is 6.49M and currently, short sellers hold a 1.10% of that float. On September 11, 2024, CPHI’s average trading volume was 139.68K shares.
CPHI’s Market Performance
The stock of China Pharma Holdings Inc. (CPHI) has seen a 2.62% increase in the past week, with a 12.42% rise in the past month, and a -25.68% fall in the past quarter. The volatility ratio for the week is 7.53%, and the volatility levels for the past 30 days are at 9.39% for CPHI. The simple moving average for the past 20 days is 1.84% for CPHI’s stock, with a -44.14% simple moving average for the past 200 days.
Analysts’ Opinion of CPHI
Many brokerage firms have already submitted their reports for CPHI stocks, with Rodman & Renshaw repeating the rating for CPHI by listing it as a “Mkt Outperform.” The predicted price for CPHI in the upcoming period, according to Rodman & Renshaw is $6 based on the research report published on January 08, 2010 of the previous year 2010.
CPHI Trading at -8.83% from the 50-Day Moving Average
After a stumble in the market that brought CPHI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.50% of loss for the given period.
Volatility was left at 9.39%, however, over the last 30 days, the volatility rate increased by 7.53%, as shares sank -1.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.99% lower at present.
During the last 5 trading sessions, CPHI fell by -7.29%, which changed the moving average for the period of 200-days by -61.92% in comparison to the 20-day moving average, which settled at $0.1962. In addition, China Pharma Holdings Inc. saw -66.94% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CPHI
Current profitability levels for the company are sitting at:
- -0.67 for the present operating margin
- -0.29 for the gross margin
The net margin for China Pharma Holdings Inc. stands at -0.7. The total capital return value is set at -0.44. Equity return is now at value -74.89, with -29.39 for asset returns.
Based on China Pharma Holdings Inc. (CPHI), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.55. The interest coverage ratio of the stock is 420.43.
Currently, EBITDA for the company is 1830.0 with net debt to EBITDA at -1.2. When we switch over and look at the enterprise to sales, we see a ratio of 1.06. The receivables turnover for the company is 22.04for trailing twelve months and the total asset turnover is 0.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.84.
Conclusion
To wrap up, the performance of China Pharma Holdings Inc. (CPHI) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
